Results 141 to 150 of about 719,803 (305)
Nano-Engineered Polyaspartate-Coated Magnetite Scale Inhibitor: A Sustainable Solution for Efficient Gypsum Scale Control in Oilfield Operations [PDF]
Scaling in oilfield applications poses considerable challenges, as it can lead to a reduction in production rates, heightened operational costs, and adverse environmental impacts when hazardous chemicals are used to prevent scale precipitation.
Malcolm A. Kelland (1297143) +3 more
core +1 more source
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Scale inhibitor selection criteria for downhole (SQUEEZE) application in a chalk reservoir [PDF]
This paper describes a scale inhibitor (SI) screening study for potential application offshore in high volume (30,000 STB per day) horizontal wells in a fractured chalk reservoir.
Wattie, I +3 more
core
Experimental and Electrochemical Research of an Efficient Corrosion and Scale Inhibitor. [PDF]
Chen Y, Xing W, Wang L, Chen L.
europepmc +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis +3 more
wiley +1 more source
Effect of PPCA and DETPMP inhibitor blends on CaCO3 scale formation [PDF]
PPCA and DETPMP are two common commercial scale inhibitors used to control mineral scaling in the oil and gas industry. Normally, PPCA is regarded as a nucleation inhibitor and DETPMP as a growth inhibitor.
Neville, A., Yuan, M., Chen, T.
core
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober +16 more
wiley +1 more source
MITF maintains genome stability in nonmelanocyte lineages
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir +13 more
wiley +1 more source

